In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Avadel Pharmaceuticals plc’s stock clocked out at $8.39, up 5.40% from its previous closing price of $7.96. In other words, the price has increased by $5.40 from its previous closing price. On the day, 0.81 million shares were traded. AVDL stock price reached its highest trading level at $8.42 during the session, while it also had its lowest trading level at $7.91.
Ratios:
To gain a deeper understanding of AVDL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 0.50 whereas as Long-Term Debt/Eq ratio is at 0.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On June 12, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $27.
Oppenheimer reiterated its Outperform rating for the stock on March 05, 2024, while the target price for the stock was revised from $27 to $29.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 21 ’25 when Palczuk Linda bought 5,000 shares for $7.93 per share. The transaction valued at 39,640 led to the insider holds 67,900 shares of the business.
Thornton Peter J. bought 10,000 shares of AVDL for $80,450 on Jan 13 ’25. The Director now owns 104,055 shares after completing the transaction at $8.04 per share. On Jan 13 ’25, another insider, Ende Eric J, who serves as the Director of the company, bought 30,000 shares for $7.84 each. As a result, the insider paid 235,218 and bolstered with 208,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 810720704 and an Enterprise Value of 775786944. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.79 while its Price-to-Book (P/B) ratio in mrq is 10.97. Its current Enterprise Value per Revenue stands at 4.587 whereas that against EBITDA is -19.532.
Stock Price History:
The Beta on a monthly basis for AVDL is 1.51, which has changed by -0.47298998 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $7.39. The 50-Day Moving Average of the stock is -0.78%, while the 200-Day Moving Average is calculated to be -33.39%.
Shares Statistics:
It appears that AVDL traded 1.43M shares on average per day over the past three months and 1262750 shares per day over the past ten days. A total of 96.52M shares are outstanding, with a floating share count of 88.27M. Insiders hold about 8.65% of the company’s shares, while institutions hold 79.77% stake in the company. Shares short for AVDL as of 1740700800 were 9688205 with a Short Ratio of 6.79, compared to 1738281600 on 10552970. Therefore, it implies a Short% of Shares Outstanding of 9688205 and a Short% of Float of 11.790000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
